SHORT-TERM NOTES RECEIVABLE (Details Narrative) - USD ($) |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
|
| Principal amount | $ 1,909,500 | ||
| Accrued interest | $ 916,102 | 731,160 | |
| Accrued interest on short-term note receivable | 184,942 | $ 110,871 | |
| Expected credit losses | $ 4,697,574 | $ 4,555,000 | |
| Marizyme Notes [Member] | |||
| Interest rate | 18.00% | ||
| Expected credit losses | $ 4,697,574 | ||
| Location, Statement of Income, Balance [Axis]: us-gaap:OtherIncomeMember | |||
| Accrued interest on short-term note receivable | $ 184,942 | $ 110,871 | |
| X | ||||||||||
- Definition Accrued interest on short-term note receivable. No definition available.
|
| X | ||||||||||
- Definition Amount of allowance for credit loss on financing receivable, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average effective interest rate during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of interest payable on debt, including, but not limited to, trade payables. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|